Company Email Format

APIM Therapeutics

Biotechnology Research No 7 employees

Employees: 7
Contacts: 3
Emails: 3
Phones: 1

apimtherapeutics.com LinkedIn Crunchbase

APIM Therapeutics Overview

Headquarters: No
Phone Number: Available in AeroLeads
Website: apimtherapeutics.com
Industry: Biotechnology Research
Employees: 7
Founded: 2010
Funding: 3.0M
Company Email: Available in AeroLeads
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

Biotechnology Oncology ATX-101 PCNA & stress responses

About APIM Therapeutics

APIM Therapeutics is a venture capital financed Norwegian biotech company focusing on the development of novel treatments in the fields of oncology and inflammation. Our lead drug, ATX-101, is a first-in-class peptide drug candidate targeting a novel therapeutic intervention point involved in cellular stress defense mechanisms. ATX-101 is currently in phase II.

APIM Therapeutics Contact Details

People in AeroLeads: 4
With contact data: 3
Email contacts: 3; 75.0% coverage
Phone contacts: 1; 25.0% coverage

APIM Therapeutics Org Chart

Sample employees and titles

Name	Title	Location	Contact
Gokhan Batur	Chief Executive Officer - Venture	Thalwil, Zurich, Switzerland	Email Phone
Marit Otterlei	Chief Scientific Officer at Apim	Trondheim, Trøndelag, Norway	Email
Birgitte Gangmark Villmo	Investment Director at Investinor		View
Kostas Alevizopoulos		Yverdon, Vaud, Switzerland	Email